
Yüksel Ürün/X
Apr 9, 2025, 09:30
Yüksel Ürün: HER2 testing is evolving – update for a companion diagnostic assay
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:
“HER2 testing is evolving.
Current IHC = poor sensitivity and discordance
New tools: QIF, RNA, AI, digital scoring
Needed for HER2-low and -ultralow ADC decisions.”
HER2 testing: evolution and update for a companion diagnostic assay
Authors: Charles J. Robbins, Katherine M. Bates, David L. Rimm
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 19:10
Apr 14, 2025, 19:01
Apr 14, 2025, 18:39
Apr 14, 2025, 18:22
Apr 14, 2025, 18:21
Apr 14, 2025, 18:16
Apr 14, 2025, 18:13